Long Acting Drug Delivery Technologies Services Market Size, Share & Trends Analysis Report By Technique (Long-Acting Injectables, Long-Acting Hydrogels, Long-Acting Implants, Long-Acting Microneedles, And Nanocrystal Suspensions), Dosage Form (Injectables, Implantable, Topical/Transdermal, Vaginal), Type Of Molecule Delivered, Material Used And End-User, Region And Segment Forecasts, 2023-2031

Report Id: 2565 Pages: 180 Last Updated: 12 July 2024 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of acting drug delivery technologies services market-

By Technique-

  • Long-Acting Injectables
  • Long-Acting Hydrogels
  • Long-Acting Implants
  • Long-Acting Microneedles
  • Nanocrystal Suspensions

Long Acting Drug Delivery Technologies Services Market seg

By Dosage Form-

  • Injectables
  • Implantable
  • Topical/Transdermal
  • Vaginal
  • Other Dosage Forms

By Type of Molecule Delivered-

  • Small Molecules
  • Biologics
  • Other Molecules

By Material Used-

  • Polymer Based
  • Non-Polymer Based

By End User-

  • Biopharmaceutical and Life science Companies
  • Research and Academics

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Long-Acting Drug Delivery Technologies and Services Market Snapshot

Chapter 4. Global Long-Acting Drug Delivery Technologies and Services Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Technique Estimates & Trend Analysis

5.1. by Technique & Market Share, 2019 & 2031

5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Technique:

5.2.1. Long-Acting Injectables

5.2.2. Long-Acting Hydrogels

5.2.3. Long-Acting Implants

5.2.4. LongActing Microneedles

5.2.5. Nanocrystal Suspensions

Chapter 6. Market Segmentation 2: By Type of Molecule Delivered Estimates & Trend Analysis

6.1. By Type of Molecule Delivered & Market Share, 2019 & 2031

6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Type of Molecule Delivered:

6.2.1. Small Molecules

6.2.2. Biologics

6.2.3. Other Molecules (Peptides)

Chapter 7. Market Segmentation 3: by Material-Used Estimates & Trend Analysis

7.1. by Material-Used & Market Share, 2019 & 2031

7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Material-Used:

7.2.1. Polymer-based

7.2.2. Non-polymer based

Chapter 8. Market Segmentation 4: By Dosage Forms Estimates & Trend Analysis

8.1. By Dosage Forms & Market Share, 2019 & 2031

8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Dosage Forms:

8.2.1. Long-acting Injectables

8.2.2. Long-acting Implantable

8.2.3. Topical / Transdermal

8.2.4. Vaginal   

8.2.5. Other Dosage Forms

Chapter 9. Market Segmentation 5: By Distribution Channels Estimates & Trend Analysis

9.1. By Distribution Channels & Market Share, 2019 & 2031

9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Distribution Channels:

9.2.1. Hospitals and Retail Pharmacies

9.2.2. Research and Academics

9.2.3. Others

Chapter 10. Long-Acting Drug Delivery Technologies and Services Market Segmentation 6: Regional Estimates & Trend Analysis

10.1. North America

10.1.1. North America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2023-2031

10.1.2. North America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Type of Molecule Delivered, 2023-2031

10.1.3. North America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Material-Used, 2023-2031

10.1.4. North America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Dosage Forms, 2023-2031

10.1.5. North America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channels, 2023-2031

10.1.6. North America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

10.2. Europe

10.2.1. Europe Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2023-2031

10.2.2. Europe Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Type of Molecule Delivered, 2023-2031

10.2.3. Europe Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Material-Used, 2023-2031

10.2.4. Europe Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Dosage Forms, 2023-2031

10.2.5. Europe Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channels, 2023-2031

10.2.6. Europe Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

10.3. Asia Pacific

10.3.1. Asia Pacific Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2023-2031

10.3.2. Asia Pacific Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Type of Molecule Delivered, 2023-2031

10.3.3. Asia-Pacific Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Material-Used, 2023-2031

10.3.4. Asia-Pacific Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Dosage Forms, 2023-2031

10.3.5. Asia-Pacific Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channels, 2023-2031

10.3.6. Asia Pacific Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

10.4. Latin America

10.4.1. Latin America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2023-2031

10.4.2. Latin America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Type of Molecule Delivered, 2023-2031

10.4.3. Latin America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Material-Used, 2023-2031

10.4.4. Latin America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Dosage Forms, 2023-2031

10.4.5. Latin America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channels, 2023-2031

10.4.6. Latin America Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

10.5. Middle East & Africa

10.5.1. Middle East & Africa Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Technique, 2023-2031

10.5.2. Middle East & Africa Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Type of Molecule Delivered, 2023-2031

10.5.3. Middle East & Africa Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by Material-Used, 2023-2031

10.5.4. Middle East & Africa Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts By Dosage Forms, 2023-2031

10.5.5. Middle East & Africa Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and By Distribution Channels, 2023-2031

10.5.6. Middle East & Africa Long-Acting Drug Delivery Technologies and Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

Chapter 11. Competitive Landscape

11.1. Major Mergers and Acquisitions/Strategic Alliances

11.2. Company Profiles

11.2.1. Adare Pharma Solutions

11.2.2. Alkermes

11.2.3. AMW Gmb   

11.2.4. Camurus AB

11.2.5. Corium, LLC.

11.2.6. Creative Biolabs

11.2.7. Delpor, Inc.

11.2.8. Durect Corporation

11.2.9. Hanmi Pharm Co Ltd.

11.2.10. Heron Therapeutics, Inc.

11.2.11. Integral BioSystems

11.2.12. NANEXA AB

11.2.13. Other Prominent Players

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
9815
Security Code field cannot be blank!

Frequently Asked Questions

Long Acting Drug Delivery Technologies Services Market Size is valued at USD 13.7 Bn in 2023 and is predicted to reach USD 30.2 Bn by the year 2031

Long Acting Drug Delivery Technologies Services Market is predicted to develop at a 10.6% CAGR during the forecast period for 2024-2031.

Creative Biolabs, For Doz Pharma, Innocore Pharmaceuticals, Integral BioSystems, LATITUDE Pharmaceuticals, Navin Saxena Research and Technology Centre

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying